10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,958 | -37.1% | 455 | 0.0% | 0.01% | -28.6% |
| Q2 2022 | $20,589 | -40.5% | 455 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $34,612 | -48.9% | 455 | 0.0% | 0.01% | -47.6% |
| Q4 2021 | $67,777 | +2.3% | 455 | 0.0% | 0.02% | -8.7% |
| Q3 2021 | $66,239 | -25.7% | 455 | 0.0% | 0.02% | -30.3% |
| Q2 2021 | $89,098 | +8.2% | 455 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $82,355 | +27.8% | 455 | 0.0% | 0.03% | +13.8% |
| Q4 2020 | $64,428 | +13.6% | 455 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $56,729 | +39.6% | 455 | 0.0% | 0.03% | +31.8% |
| Q2 2020 | $40,636 | +43.3% | 455 | 0.0% | 0.02% | +22.2% |
| Q1 2020 | $28,356 | -18.3% | 455 | 0.0% | 0.02% | -5.3% |
| Q4 2019 | $34,694 | +51.3% | 455 | 0.0% | 0.02% | +35.7% |
| Q3 2019 | $22,932 | – | 455 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |